Literature DB >> 33247399

Gastrointestinal dysfunction in the synucleinopathies.

Kathryn A Chung1, Ronald F Pfeiffer2.   

Abstract

Interest in gastrointestinal dysfunction in Parkinson's disease has blossomed over the past 30 years and has generated a wealth of investigation into this non-motor aspect of the disorder, research that has encompassed its pathophysiology, its clinical features, and its impact on quality of life. The question of gastrointestinal dysfunction in the other synucleinopathies has not received nearly as much attention, but information and knowledge are growing. In this review, the current knowledge, controversies, and gaps in our understanding of the pathophysiology of gastrointestinal dysfunction in Parkinson's disease and the other synucleinopathies will be addressed, and extended focus will be directed toward the clinical problems involving saliva management, swallowing, gastric emptying, small intestinal function, and bowel function that are so problematic in these disorders.

Entities:  

Keywords:  Constipation; Dysphagia; Gastrointestinal; Gastroparesis; Parkinsonism; Synuclein

Year:  2020        PMID: 33247399     DOI: 10.1007/s10286-020-00745-7

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  241 in total

1.  Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology.

Authors:  Heiko Braak; Rob A I de Vos; Jürgen Bohl; Kelly Del Tredici
Journal:  Neurosci Lett       Date:  2005-12-05       Impact factor: 3.046

2.  Pathological lesions in colonic biopsies during Parkinson's disease.

Authors:  T Lebouvier; T Chaumette; P Damier; E Coron; Y Touchefeu; S Vrignaud; P Naveilhan; J-P Galmiche; S Bruley des Varannes; P Derkinderen; M Neunlist
Journal:  Gut       Date:  2008-12       Impact factor: 23.059

3.  Alpha-synuclein in Lewy bodies.

Authors:  M G Spillantini; M L Schmidt; V M Lee; J Q Trojanowski; R Jakes; M Goedert
Journal:  Nature       Date:  1997-08-28       Impact factor: 49.962

4.  Vagotomy and subsequent risk of Parkinson's disease.

Authors:  Elisabeth Svensson; Erzsébet Horváth-Puhó; Reimar W Thomsen; Jens Christian Djurhuus; Lars Pedersen; Per Borghammer; Henrik Toft Sørensen
Journal:  Ann Neurol       Date:  2015-07-17       Impact factor: 10.422

5.  Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease.

Authors:  S J Qualman; H M Haupt; P Yang; S R Hamilton
Journal:  Gastroenterology       Date:  1984-10       Impact factor: 22.682

6.  Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.

Authors:  Kathleen M Shannon; Ali Keshavarzian; Ece Mutlu; Hemraj B Dodiya; Delia Daian; Jean A Jaglin; Jeffrey H Kordower
Journal:  Mov Disord       Date:  2011-07-15       Impact factor: 10.338

7.  Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases.

Authors:  Kathleen M Shannon; Ali Keshavarzian; Hemraj B Dodiya; Shriram Jakate; Jeffrey H Kordower
Journal:  Mov Disord       Date:  2012-05-01       Impact factor: 10.338

8.  Frequency of bowel movements and the future risk of Parkinson's disease.

Authors:  R D Abbott; H Petrovitch; L R White; K H Masaki; C M Tanner; J D Curb; A Grandinetti; P L Blanchette; J S Popper; G W Ross
Journal:  Neurology       Date:  2001-08-14       Impact factor: 9.910

9.  Life style risks of Parkinson's disease: association between decreased water intake and constipation.

Authors:  Akira Ueki; Mieko Otsuka
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

10.  Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease.

Authors:  David Hilton; Madeleine Stephens; Leanne Kirk; Philip Edwards; Ross Potter; John Zajicek; Ellie Broughton; Hannah Hagan; Camille Carroll
Journal:  Acta Neuropathol       Date:  2013-11-17       Impact factor: 17.088

View more
  6 in total

Review 1.  Gastrointestinal Dysfunction in Parkinson's Disease.

Authors:  Delaram Safarpour; Kaveh Sharzehi; Ronald F Pfeiffer
Journal:  Drugs       Date:  2022-01-25       Impact factor: 9.546

2.  Longitudinal metabolomics profiling of serum amino acids in rotenone-induced Parkinson's mouse model.

Authors:  Zhenzhen Yan; Fan Yang; Shirong Wen; Wencai Ding; Yao Si; Ruihua Li; Kai Wang; Lifen Yao
Journal:  Amino Acids       Date:  2022-01-14       Impact factor: 3.520

Review 3.  Movement Disorders and the Gut: A Review.

Authors:  Lauren S Talman; Ronald F Pfeiffer
Journal:  Mov Disord Clin Pract       Date:  2022-02-05

Review 4.  Gastrointestinal Dysfunction in Parkinson's Disease.

Authors:  Casper Skjærbæk; Karoline Knudsen; Jacob Horsager; Per Borghammer
Journal:  J Clin Med       Date:  2021-01-31       Impact factor: 4.241

Review 5.  Assessment of Gastrointestinal Autonomic Dysfunction: Present and Future Perspectives.

Authors:  Ditte S Kornum; Astrid J Terkelsen; Davide Bertoli; Mette W Klinge; Katrine L Høyer; Huda H A Kufaishi; Per Borghammer; Asbjørn M Drewes; Christina Brock; Klaus Krogh
Journal:  J Clin Med       Date:  2021-03-31       Impact factor: 4.241

Review 6.  Gastroparesis in Parkinson Disease: Pathophysiology, and Clinical Management.

Authors:  Heithem Soliman; Benoit Coffin; Guillaume Gourcerol
Journal:  Brain Sci       Date:  2021-06-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.